Cirtran (CIRX) Common Equity (2010 - 2026)

Cirtran (CIRX) has reported Common Equity for 15 consecutive years, with -$23.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Common Equity rose 8.48% year-over-year to -$23.0 million; the trailing twelve-month figure through Jun 2026 stood at -$23.0 million (up 8.48% YoY), and the FY2025 full-year result was -$25.1 million, down 2.87% from the prior year.
• Common Equity steadied at -$23.0 million in Q2 2026 per CIRX's latest filing, from -$22.9 million in the prior quarter.
• Across five years, Common Equity topped out at -$21.8 million in Q4 2023 and bottomed at -$43.0 million in Q3 2023.
• Historically, Common Equity has averaged -$30.8 million across 5 years, with a median of -$25.1 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Common Equity soared 48.23% in 2023, then fell 12.06% in 2024.
• Over 5 years, Common Equity stood at -$42.1 million in 2022, then jumped by 48.23% to -$21.8 million in 2023, then dropped by 12.06% to -$24.4 million in 2024, then decreased by 2.87% to -$25.1 million in 2025, then climbed by 8.42% to -$23.0 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered -$23.0 million, -$22.9 million, and -$25.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.